LifeStance Health Group enters $290.0 million term loan and $100.0 million revolver
LifeStance's subsidiary entered a new credit agreement with Capital One as administrative agent, funding a $290.0 million senior secured term loan on December 19, 2024 and establishing a $100.0 million revolving facility. Proceeds were used to repay and terminate the existing credit agreement dated May 4, 2022, and both facilities mature on the fifth anniversary of the closing date.
Key points
- Term loan facility of $290.0 million, funded on December 19, 2024, with interest at adjusted term SOFR (0.00% floor) plus 3.00% or a base rate plus 2.00%
- Revolving facility commitments of up to $100.0 million, with a 0.45% per annum undrawn commitment fee subject to leverage-based stepdowns
- Proceeds used to repay all outstanding loans under the May 4, 2022 credit agreement, which was terminated
- Obligations are guaranteed by Holdings and certain subsidiaries and secured by substantially all assets of the Borrower, Holdings and subsidiary guarantors
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 19, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.